Comparative genomic hybridisation identifies two variants of smoldering multiple myeloma
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Summary: Two variants of smoldering multiple myeloma (SMM) have been recognised: (i) an evolving type, characterised by a progressive increase in the M‐protein size and short time to progression to overt multiple myeloma (MM) and (ii) a non‐evolving type, with a long‐lasting, stable M‐protein and longer time to progression. Comparative genomic hybridisation (CGH) analyses in both subtypes of SMM (seven evolving and eight non‐evolving SMM) were performed. Evolving SMM showed cytogenetic changes consistent with those found in de novo symptomatic MM (1q gains, chromosome 13 deletions) while the non‐evolving variant showed no 1q gains and deletions were uncommon.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genomic abnormalities in monoclonal gammopathy of undetermined significance
Fonseca, R., Bailey, R. J., Ahmann, G. J., Rajkumar, S. V., Hoyer, J. D., Lust, J. A., Kyle, R. A., Gertz, M. A., Greipp, P. R., & Dewald, G. W. (2002) · Blood · doi:10.1182/blood.v100.4.1417.h81602001417_1417_1424 · Cited by 348 · cited 3×
“Taking into account that most of the patients with evolving SMM have a previously recognised MGUS (Rosiñol et al, 2003), it could be speculated that these patients acquire the cytogenetic changes in the MGUS phase, as their disease is a slowly progressive symptomatic myeloma from the beginning.”
Background
Cited by
The molecular classification of multiple myeloma
Zhan, F., Huang, Y., Colla, S., Stewart, J. P., Hanamura, I., Gupta, S., Epstein, J., Yaccoby, S., Sawyer, J., Burington, B., et al. (2006) · Blood · doi:10.1182/blood-2005-11-013458 · Cited by 1,133
Shaughnessy, J. D., Zhan, F., Burington, B. E., Huang, Y., Colla, S., Hanamura, I., Stewart, J. P., Kordsmeier, B., Randolph, C., Williams, D. R., et al. (2007) · Blood · doi:10.1182/blood-2006-07-038430 · Cited by 914
Hanamura, I., Stewart, J. P., Huang, Y., Zhan, F., Santra, M., Sawyer, J. R., Hollmig, K., Zangarri, M., Pineda-Roman, M., van Rhee, F., et al. (2006) · Blood · doi:10.1182/blood-2006-03-009910 · Cited by 479
Zhan, F., Barlogie, B., Arzoumanian, V., Huang, Y., Williams, D. R., Hollmig, K., Pineda-Roman, M., Tricot, G., van Rhee, F., Zangari, M., et al. (2007) · Blood · doi:10.1182/blood-2006-07-037077 · Cited by 381
Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
Kumar, S. K., Callander, N. S., Alsina, M., Atanackovic, D., Biermann, J. S., Chandler, J. C., Costello, C., Faiman, M., Fung, H. C., Gasparetto, C., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0023 · Cited by 279
Metadata
- Authors
- Rosiñol, L., Carrió, A., Bladé, J., Queralt, R., Aymerich, M., Cibeira, M., Esteve, J., Rozman, M., Campo, E., & Montserrat, E.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2005-08-11
- Volume
- 130
- Issue
- 5
- Pages
- 729-732
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2050004237
- Cited by
- 46
- References
- 1
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparative genomic hybridisation identifies two variants of smoldering multiple myeloma. https://app.cochat.ai/papers/10.1111/j.1365-2141.2005.05673.x
- The paper
- Rosiñol, L., Carrió, A., Bladé, J., Queralt, R., Aymerich, M., Cibeira, M., Esteve, J., Rozman, M., Campo, E., & Montserrat, E. (2005). Comparative genomic hybridisation identifies two variants of smoldering multiple myeloma. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.2005.05673.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.